CME Group Inc.

“CME combines benchmark derivatives franchises, clearing network effects, strong cash generation, and prudent balance-sheet management into a rare, durable financial infrastructure asset. The problem is not business quality but price versus forward return: with the stock around fair value and reinvestment runway only moderate, long-term returns likely skew toward respectable rather than outstanding. It is a strong company worth owning at the right price, but not an obvious buy today.”